Back to top
more

Nu Skin Enterprises (NUS)

(Delayed Data from NYSE)

$12.28 USD

12.28
469,629

-0.03 (-0.24%)

Updated Apr 29, 2024 04:00 PM ET

After-Market: $12.35 +0.07 (0.57%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 30% (177 out of 252)

Industry: Cosmetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Nu Skin Enterprises (NUS) Surpasses Q2 Earnings Estimates

by Zacks Equity Research

Nu Skin (NUS) delivered earnings and revenue surprises of 1.89% and 2.36%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Nu Skin (NUS) Gears Up for Q2 Earnings: What's in Store?

by Zacks Equity Research

Nu Skin's (NUS) second-quarter 2023 performance will likely reflect macroeconomic challenges like rising global inflation. Also, unfavorable currency rates are a concern.

COTY Inks Agreement to Offload 3.6% of Its Stake in Wella

by Zacks Equity Research

COTY inks a letter of intent to divest part of its stake in Wella to IGF Wealth Management. This is likely to help the company meet its leverage goal toward 3X as it exits CY23.

Are Investors Undervaluing Nu Skin Enterprises (NUS) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Helen of Troy (HELE) Beats Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Helen of Troy (HELE) delivered earnings and revenue surprises of 19.75% and 2.46%, respectively, for the quarter ended May 2023. Do the numbers hold clues to what lies ahead for the stock?

Nu Skin (NUS) Down 12.5% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Nu Skin (NUS) Q1 Earnings & Revenues Top Estimates, Dip Y/Y

by Zacks Equity Research

Nu Skin's (NUS) first-quarter 2023 results reflect difficult year-over-year comparisons and macroeconomic hurdles. However, a focus on the Nu Vision 2025 strategy has been working well.

Nu Skin Enterprises (NUS) Beats Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Nu Skin (NUS) delivered earnings and revenue surprises of 12.12% and 0.92%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

AB InBev (BUD) to Report Q1 Earnings: What's on the Cards?

by Zacks Equity Research

AB InBev's (BUD) Q1 results are expected to reflect gains from premiumization efforts, expansion of the beyond beer portfolio and digital initiatives, offset by elevated costs and currency headwinds.

Factors Influencing Monster Beverage's (MNST) Q1 Earnings

by Zacks Equity Research

Monster Beverage (MNST) Q1 results are expected to reflect gains from the solid energy drinks business, continued pricing actions and product innovation. However, cost inflation has been concerning.

Factors to Consider Ahead of Nu Skin's (NUS) Q1 Earnings

by Zacks Equity Research

Nu Skin's (NUS) first-quarter performance is likely to reflect macro headwinds like prolonged COVID-related disruptions, unfavorable currency rates and global inflation.

Is Nu Skin Enterprises (NUS) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Nu Skin Enterprises (NUS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

Nu Skin (NUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Procter & Gamble (PG) Beats on Q3 Earnings and Sales, Ups View

by Zacks Equity Research

Procter & Gamble's (PG) Q3 results benefit from robust pricing and a favorable mix, along with strength across its segments.

e.l.f. Beauty (ELF) Hits Fresh High: Is There Still Room to Run?

by Zacks Equity Research

e.l.f. Beauty (ELF) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Nu Skin's (NUS) Nu Vision 2025 Strategy Bodes Well, Costs Hurt

by Zacks Equity Research

Nu Skin (NUS) benefits from its product launches and Nu Vision 2025 strategy amid challenges like cost inflation and currency volatility.

Nu Skin (NUS) Hurt by Cost Inflation, Adverse Currency Movements

by Zacks Equity Research

Nu Skin (NUS) bears the brunt of COVID-related disruptions, unfavorable currency movements and global inflation.

Why Is Nu Skin (NUS) Down 9.2% Since Last Earnings Report?

by Zacks Equity Research

Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The Estee Lauder Companies Inc. (EL) Online Sales Aid Growth

by Zacks Equity Research

The Estee Lauder Companies Inc. (EL) is benefiting from a strong online business. It has a solid presence in emerging markets, which bodes well.

Nu Skin (NUS) Q4 Earnings Top Estimates, Sales Down Y/Y

by Zacks Equity Research

Nu Skin's (NUS) fourth-quarter 2022 results reflect lower revenues and earnings on macro headwinds, continued inflation and unfavorable currency.

Nu Skin Enterprises (NUS) Q4 Earnings Surpass Estimates

by Zacks Equity Research

Nu Skin (NUS) delivered earnings and revenue surprises of 67.92% and 3.94%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Nu Skin (NUS) Readies for Q4 Earnings: Everything to Note

by Zacks Equity Research

Nu Skin's (NUS) fourth-quarter results are likely to reflect the adverse impacts of cost inflation and currency translations, whereas a focus on the Nu Vision 2025 strategy is likely to have been an upside.

Service Corporation (SCI) Queued for Q4 Earnings: Things to Note

by Zacks Equity Research

Service Corporation's (SCI) fourth-quarter 2022 performance will likely reflect the adverse impact of rising inflationary pressure. Rising corporate general and administrative costs are a concern.

Factors to Watch Ahead of Kraft Heinz's (KHC) Q4 Earnings

by Zacks Equity Research

Kraft Heinz's (KHC) fourth-quarter results are likely to reflect gains from pricing actions and a focus on the operating model amid cost and supply-chain concerns.

Nu Skin Enterprises (NUS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

Nu Skin (NUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.